• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经状态、脂肪组织与乳腺癌风险:雌激素替代疗法的影响

Menopausal status, adipose tissue, and breast cancer risk: impact of estrogen replacement therapy.

作者信息

Eden John A

机构信息

Women's Health and Research Institute of Australia, Bathurst St, Sydney, Australia.

出版信息

Horm Mol Biol Clin Investig. 2013 Aug;14(2):57-63. doi: 10.1515/hmbci-2013-0007.

DOI:10.1515/hmbci-2013-0007
PMID:25436720
Abstract

The seeds of breast cancer are likely sown in the first two or three decades of life. Rapid weight gain and height in infancy predict breast cancer risk in later life. The age at first pregnancy is also a strong predictor for breast cancer; the earlier the first full-term pregnancy, then the lower the risk of breast cancer in later life. It has been postulated that the breast stem cell number may be the factor linking these observations together. Menopause, per se, is associated with an increase in central adiposity, which is reversed by hormone replacement usage. Breast and nonbreast fat both produce estrogens and cytokines that may promote the growth of small breast cancers making them appear earlier. Obesity also is associated with metabolic syndrome, which is a risk factor for breast cancer. The breast cancer stem cells make up only around 1%-2% of the tumor mass and, yet, are the likely driver for much of a breast cancer's behavior. Future research into breast cancer biology, especially into the cancer stem cells is likely to translate into novel methods of treatment and prevention of this common cancer.

摘要

乳腺癌的种子可能在生命的最初二三十年就已种下。婴儿期体重和身高的快速增长预示着日后患乳腺癌的风险。首次怀孕的年龄也是乳腺癌的一个重要预测因素;首次足月妊娠越早,日后患乳腺癌的风险就越低。据推测,乳腺干细胞数量可能是将这些观察结果联系在一起的因素。更年期本身与中心性肥胖增加有关,而激素替代疗法可逆转这种情况。乳腺脂肪和非乳腺脂肪都会产生雌激素和细胞因子,它们可能促进小乳腺癌的生长,使其更早出现。肥胖还与代谢综合征有关,而代谢综合征是乳腺癌的一个风险因素。乳腺癌干细胞仅占肿瘤组织的约1%-2%,然而,它们很可能是乳腺癌许多行为的驱动因素。未来对乳腺癌生物学的研究,尤其是对癌症干细胞的研究,可能会转化为治疗和预防这种常见癌症的新方法。

相似文献

1
Menopausal status, adipose tissue, and breast cancer risk: impact of estrogen replacement therapy.绝经状态、脂肪组织与乳腺癌风险:雌激素替代疗法的影响
Horm Mol Biol Clin Investig. 2013 Aug;14(2):57-63. doi: 10.1515/hmbci-2013-0007.
2
Breast cancer, stem cells and sex hormones. Part 3: the impact of the menopause and hormone replacement.乳腺癌、干细胞和性激素。第 3 部分:绝经和激素替代的影响。
Maturitas. 2011 Feb;68(2):129-36. doi: 10.1016/j.maturitas.2010.11.005. Epub 2010 Dec 8.
3
Influence of obesity on breast cancer receptor status and prognosis.肥胖对乳腺癌受体状态及预后的影响。
Expert Rev Anticancer Ther. 2009 Aug;9(8):1091-101. doi: 10.1586/era.09.71.
4
Hormone replacement therapy and cancer.激素替代疗法与癌症。
Gynecol Endocrinol. 2001 Dec;15(6):453-65.
5
Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.更年期医学中的争议问题II. 激素替代疗法与癌症。国际绝经学会专家研讨会。2001年6月9日至12日,意大利比萨大教堂歌剧院
Climacteric. 2001 Sep;4(3):181-93.
6
Interaction between menopausal status and obesity in affecting breast cancer risk.绝经状态与肥胖在影响乳腺癌风险方面的相互作用。
Maturitas. 2010 May;66(1):33-8. doi: 10.1016/j.maturitas.2010.01.019. Epub 2010 Feb 23.
7
Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.血清高密度脂蛋白胆固醇、代谢谱与乳腺癌风险。
J Natl Cancer Inst. 2004 Aug 4;96(15):1152-60. doi: 10.1093/jnci/djh216.
8
Why does oestrogen-only hormone therapy have such a small impact on breast cancer risk? A hypothesis.为什么雌激素单一激素疗法对乳腺癌风险的影响如此之小?一种假说。
Gynecol Endocrinol. 2011 Mar;27(3):170-5. doi: 10.3109/09513590.2010.488778. Epub 2010 May 26.
9
Relationship of body weight to menarcheal and menopausal age: implications for breast cancer risk.体重与初潮年龄和绝经年龄的关系:对乳腺癌风险的影响。
J Clin Endocrinol Metab. 1981 Mar;52(3):488-93. doi: 10.1210/jcem-52-3-488.
10
Menopausal estrogen replacement therapy and breast cancer.更年期雌激素替代疗法与乳腺癌
Arch Intern Med. 1991 Jan;151(1):67-72.

引用本文的文献

1
Identification of genes and pathways associated with menopausal status in breast cancer patients using two algorithms.使用两种算法鉴定与乳腺癌患者绝经状态相关的基因和通路。
BMC Womens Health. 2024 Jan 2;24(1):4. doi: 10.1186/s12905-023-02846-7.
2
Clinical study on the prevalence and comparative analysis of metabolic syndrome and its components among Chinese breast cancer women and control population.中国乳腺癌女性与对照人群中代谢综合征及其组分的患病率及对比分析的临床研究
J Cancer. 2018 Jan 1;9(3):548-555. doi: 10.7150/jca.22968. eCollection 2018.
3
Calycosin Orchestrates Osteogenesis of Danggui Buxue Tang in Cultured Osteoblasts: Evaluating the Mechanism of Action by Omics and Chemical Knock-out Methodologies.
毛蕊异黄酮调控当归补血汤在培养成骨细胞中的成骨作用:通过组学和化学敲除方法评估其作用机制
Front Pharmacol. 2018 Feb 1;9:36. doi: 10.3389/fphar.2018.00036. eCollection 2018.